75 YEARS:
MACEDONIAN SUCCESS
STORY
Powered by SAP
MHRA GMP Compliance Certified
JAZMP GMP Compliance Certified
RNMA PIC/s GMP Compliance Certified
JFDA Approved
HACCP Certified
EU, JAS, USDA-NOP Organic Production Certified
ISO 9001, ISO 14001, ISO 13485
CE Certified
FAIRWILD Certified
Established: 15 August 1936
Main Activities: Pharmaceuticals, Chemicals, Cosmetics, Botanicals
No. of employees: 1,050 in HQ and + 300 abroad
No. of shareholders: > 5,500
Alkaloid in General
Sales network comprising 12
subsidiaries and 3 Rep. Offices
headed from the base in Macedonia.
Alkaloid in General
In the past 13 years, the Company underwent and investment cycle
worth nearly EUR 100 mil, allocated mainly in the pharmaceuticals
segment:
Investments
• Factories for solid dosage forms and for semi-synthetic
cephalosporines (cGMP)
• Warehouses, storage facilities and their infrastructure
• Microbiological and Chemical Laboratories
• IT Segment; Implementation of SAP/ERP; DMS; CRM etc.
• New Institute for Development and Quality Control
• New production facility in Belgrade, Republic of Serbia
• Production equipment (continuous)
Investments
Pharmaceutical industry: Dynamic state of affairs
All these investments led to obtaining various GMP certificates for the
international markets (British Medicines and Healthcare products
Regulatory Agency – MHRA; Slovenian Agency for Drugs and
Medicinal Products; Romanian Ministry of Health; Jordan Food and
Drugs Administration, Pre-US FDA Approval etc.) thus giving the
company the right to market its products worldwide thereby increasing
its level of competence.
Leading Brands
• Launched in 1957 with more than 10 bil. tablets sold so far, present
in the markets of 27 countries
• Superbrand for Serbia (2007), Bosnia & Herzegovina (2008) and
Macedonia (2009)
• 4 New extensions since year 2005:
Consumers do not communicate with anonymous products,
but they built a relationship with a brand, indentifying therein their own
values and beliefs. Investment in brands, is one of our priorities.
The golden superbrand: CAFFETIN
Leading Brands
• Synonym for quality, confidence and tradition
• First introduced in 1977 as babycare collection containing only 5
products. Today, the portfolio contains over 30 products with more than
100 million pieces sold.
• 60% market share in Macedonia. Well positioned in other SEE markets.
• Superbrand for Bosnia & Herzegovina (2008), Macedonia and Croatia
(in 2009)
Standings and prospects
All 14 subsidiaries with over 300 employments abroad are in the
function of enhancing the export orientation of the Company. Alkaloid
is making strong investment efforts for building competent marketing
and sales teams.
6th Pharmaceutical Industry in South Eastern Europe.
Alkaloid’s strategic policy for growth is also aimed at acquiring
pharmaceutical companies outside of Macedonia. First production
facility in Belgrade was opened in 2010.
Alkaloid’s products are present in almost 30 markets worldwide.
Standings and prospects
Alkaloid is open for all types of cooperation and synergies.
Various types of alliances: license production agreements,
contract manufacturing production, distributions for multinationals
etc.
Present pharmaceuticals portfolio: 144 pharmaceutical products
with over 340 forms. One cannot excel in all.
Specialization in cephalosporins (one of the few manufacturers),
cardio preparations and CNS drugs.
Focus on pharmaceuticals and correlated activities.
Standings and prospects
The success in Alkaloid’s operations is mostly due to the quality of
the products, the well-trained personnel working in the company,
the very brand Alkaloid and the individual brands.
Appropriate know-how along with well-thought flexible and vigilant
strategy for individual market(s) approach is also an important
condition.
Sustainable products, team work and proactive marketing concept
stands for added value to our performance.
Alkaloid: 3rd world country manufacturer?!
With every new market conquered with our own efforts, the
success of the company becomes a success of our country.
A Partner of Choice
F. Hoffmann - La Roche Sanofi Aventis Italfarmaco Valeant (Pharmaswiss) Talecris Pfizer Nycomed Novartis Mundifarma B. Braun GSK Actavis
Sandoz Shire
• More than 20 products in the license program
• Over 150 products on consignment and distribution stock (distributed
through Alkaloid Cons Ltd.)
A Partner of Choice
Botanicals Segment: (EU, JAS, USDA-NOP Organic Production Certified /
FAIRWILD Certified)
2005: Production agreement with the US company Aveda (Member of Estèe
Lauder Group) for production of Comforting tea.
2011: New production agreement with Arbonne International from USA for
detox tea intended for the markets of Canada, USA, UK and the Pacific
region.
Medicine: Certificate for CE compliance by KEMA Quality BV for
haemodialysis solutions and X-ray films).
1981: Established partnership with FUJI Corporation, Japan for X-ray films.
2009: Alkaloid entered into cooperation agreement with the Japaneese
NIPRO for haemodialysis solution.
1977: Cooperation with Merck from Germany for production of argentum
salts.
SALES (in 000 EUR)
0
20000
40000
60000
80000
100000
120000
2006 2007 2008 2009 2010 2011
57
.79
7
69
.29
3
77
.21
6
89
.17
4
96
.46
9
10
8.0
00
2006-2010: Consolidated
2011: Projected
Investor Information
2006 2007 2008 2009 2010
Jan-Sep
2011
No. of shares 166,647 215,729 135,966 90,556 72,709 63,689
in EUR mil. 12.831 33.144 16.173 6.483 4.950 4.466
Trade with Alkaloid’s shares on the MSE
Current market capitalization:
~ 100,000,000 - 115,000,000 EUR
Alkaloid’s shares stand for one of the most liquid and most traded
shares on the first official market on the Macedonian stock
exchange.
According to MSE indicators:
1 EUR = 61.5 MKD
Future Focus
Further development of the pharmaceutical segment, satisfying the needs
of the stakeholders and contributing to the social needs of the nation.
Maintain the trend of growth and development via:
• Entry into new markets
• Increase of production and export volume
• Expanding the product portfolio
• Licensing foreign companies
• Acquisition of companies in pharmaceutical industry
• Building higher brand awareness
Besides being recognized as stabile and reliable company, acknowledged
partner with years of international experience, open for new partnerships
and all forms of cooperation, Alkaloid shall strive to earn the title: A
STABILE PARTNER FOR THE FUTURE